Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1628


Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis.

Graetz C, Gröger A, Luessi F, Salmen A, Zöller D, Schultz J, Siller N, Fleischer V, Bellenberg B, Berthele A, Biberacher V, Havla J, Hecker M, Hohlfeld R, Infante-Duarte C, Kirschke JS, Kümpfel T, Linker R, Paul F, Pfeuffer S, Sämann P, Toenges G, Weber F, Zettl UK, Jahn-Eimermacher A, Antony G, Groppa S, Wiendl H, Hemmer B, Mühlau M, Lukas C, Gold R, Lill CM, Zipp F.

Mult Scler. 2018 Mar 1:1352458518763541. doi: 10.1177/1352458518763541. [Epub ahead of print]


Corrigendum to 'Effects of Delayed-Release Dimethyl Fumarate (DMF) on Health-Related Quality of Life in Patients With Relapsing-Remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies: [Clinical Therapeutics 36 (2014) 1958-1971].

Kita M, Fox RJ, Gold R, Giovannoni G, Phillips JT, Sarda SP, Kong J, Viglietta V, Sheikh SI, Okwuokenye M, Kappos L.

Clin Ther. 2018 Mar 7. pii: S0149-2918(18)30055-9. doi: 10.1016/j.clinthera.2018.02.005. [Epub ahead of print] No abstract available.


Impact and cost-effectiveness of care farms on health and well-being of offenders on probation: a pilot study.

Elsey H, Bragg R, Elings M, Brennan C, Farragher T, Tubeuf S, Gold R, Shickle D, Wickramasekera N, Richardson Z, Cade J, Murray J.

Southampton (UK): NIHR Journals Library; 2018 Feb.


Treatment choices and neuropsychological symptoms of a large cohort of early MS.

von Bismarck O, Dankowski T, Ambrosius B, Hessler N, Antony G, Ziegler A, Hoshi MM, Aly L, Luessi F, Groppa S, Klotz L, Meuth SG, Tackenberg B, Stoppe M, Then Bergh F, Tumani H, Kümpfel T, Stangel M, Heesen C, Wildemann B, Paul F, Bayas A, Warnke C, Weber F, Linker RA, Ziemann U, Zettl UK, Zipp F, Wiendl H, Hemmer B, Gold R, Salmen A.

Neurol Neuroimmunol Neuroinflamm. 2018 Mar 1;5(3):e446. doi: 10.1212/NXI.0000000000000446. eCollection 2018 May.


Oral Therapies for Multiple Sclerosis.

Faissner S, Gold R.

Cold Spring Harb Perspect Med. 2018 Mar 2. pii: a032011. doi: 10.1101/cshperspect.a032011. [Epub ahead of print]


Clinical commentary on 'Severe hypertriglyceridemia associated with teriflunomide in a patient with multiple sclerosis'.

Faissner S, Gold R.

Mult Scler. 2018 Feb 1:1352458518761188. doi: 10.1177/1352458518761188. [Epub ahead of print] No abstract available.


ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis.

Montalban X, Gold R, Thompson AJ, Otero-Romero S, Amato MP, Chandraratna D, Clanet M, Comi G, Derfuss T, Fazekas F, Hartung HP, Havrdova E, Hemmer B, Kappos L, Liblau R, Lubetzki C, Marcus E, Miller DH, Olsson T, Pilling S, Selmaj K, Siva A, Sorensen PS, Sormani MP, Thalheim C, Wiendl H, Zipp F.

Mult Scler. 2018 Feb;24(2):96-120. doi: 10.1177/1352458517751049. Epub 2018 Jan 20.


ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis.

Montalban X, Gold R, Thompson AJ, Otero-Romero S, Amato MP, Chandraratna D, Clanet M, Comi G, Derfuss T, Fazekas F, Hartung HP, Havrdova E, Hemmer B, Kappos L, Liblau R, Lubetzki C, Marcus E, Miller DH, Olsson T, Pilling S, Selmaj K, Siva A, Sorensen PS, Sormani MP, Thalheim C, Wiendl H, Zipp F.

Eur J Neurol. 2018 Feb;25(2):215-237. doi: 10.1111/ene.13536. Epub 2018 Jan 19. Erratum in: Eur J Neurol. 2018 Mar;25(3):605.


Electronic Health Record Implementation Findings at a Large, Suburban Health and Human Services Department.

Crowley K, Mishra A, Cruz-Cano R, Gold R, Kleinman D, Agarwal R.

J Public Health Manag Pract. 2018 Jan 10. doi: 10.1097/PHH.0000000000000768. [Epub ahead of print]


Role of Nuclear Factor (Erythroid-Derived 2)-Like 2 Signaling for Effects of Fumaric Acid Esters on Dendritic Cells.

Hammer A, Waschbisch A, Knippertz I, Zinser E, Berg J, Jörg S, Kuhbandner K, David C, Pi J, Bayas A, Lee DH, Haghikia A, Gold R, Steinkasserer A, Linker RA.

Front Immunol. 2017 Dec 22;8:1922. doi: 10.3389/fimmu.2017.01922. eCollection 2017.


Activation of NPY-Y2 receptors ameliorates disease pathology in the R6/2 mouse and PC12 cell models of Huntington's disease.

Fatoba O, Kloster E, Reick C, Saft C, Gold R, Epplen JT, Arning L, Ellrichmann G.

Exp Neurol. 2018 Apr;302:112-128. doi: 10.1016/j.expneurol.2018.01.001. Epub 2018 Jan 6.


Dietary fatty acids and susceptibility to multiple sclerosis.

Haase S, Haghikia A, Gold R, Linker RA.

Mult Scler. 2018 Jan;24(1):12-16. doi: 10.1177/1352458517737372.


Grief, poetry, and the sweet unexpected.

Gold R, Jordan E.

Death Stud. 2018 Jan;42(1):16-25. doi: 10.1080/07481187.2017.1370413. Epub 2018 Jan 4.


US reproductive health and rights: beyond the global gag rule.

Gold RB, Starrs AM.

Lancet Public Health. 2017 Mar;2(3):e122-e123. doi: 10.1016/S2468-2667(17)30035-X. Epub 2017 Mar 6. No abstract available.


Delivering Bad News: Attitudes, Feelings, and Practice Characteristics Among Speech-Language Pathologists.

Gold R, Gold A.

Am J Speech Lang Pathol. 2018 Feb 6;27(1):108-122. doi: 10.1044/2017_AJSLP-17-0045.


Multiple sclerosis: Progressive multifocal leukoencephalopathy risk stratification.

Pitarokoili K, Gold R.

Nat Rev Neurol. 2017 Dec;13(12):710-712. doi: 10.1038/nrneurol.2017.161. Epub 2017 Nov 17. No abstract available.


The conserved RNA helicase YTHDC2 regulates the transition from proliferation to differentiation in the germline.

Bailey AS, Batista PJ, Gold RS, Chen YG, de Rooij DG, Chang HY, Fuller MT.

Elife. 2017 Oct 31;6. pii: e26116. doi: 10.7554/eLife.26116.


The Red Yeast Rice story: How to manufacture a tall tale from nature.

Gold KR, Gold R, Avula B, Khan IA.

Eur J Prev Cardiol. 2018 Jan;25(1):73-75. doi: 10.1177/2047487317739080. Epub 2017 Oct 31. No abstract available.


Lewis Rat Model of Experimental Autoimmune Encephalomyelitis.

Pitarokoili K, Ambrosius B, Gold R.

Curr Protoc Neurosci. 2017 Oct 23;81:9.61.1-9.61.20. doi: 10.1002/cpns.36.


Consistent efficacy of daclizumab beta across patient demographic and disease activity subgroups in patients with relapsing-remitting multiple sclerosis.

Rose JW, Giovannoni G, Wiendl H, Gold R, Havrdová E, Kappos L, Selmaj KW, Zhao J, Riester K, Tsao LC, Greenberg SJ.

Mult Scler Relat Disord. 2017 Oct;17:32-40. doi: 10.1016/j.msard.2017.06.006. Epub 2017 Jun 19.


Patient-reported outcomes in relapsing forms of MS: Real-world, global treatment experience with teriflunomide from the Teri-PRO study.

Coyle PK, Khatri B, Edwards KR, Meca-Lallana JE, Cavalier S, Rufi P, Benamor M, Brette S, Robinson M, Gold R; Teri-PRO Trial Group.

Mult Scler Relat Disord. 2017 Oct;17:107-115. doi: 10.1016/j.msard.2017.07.006. Epub 2017 Jul 6.


Publicly Funded Family Planning Under Unprecedented Attack.

Gold RB, Hasstedt K.

Am J Public Health. 2017 Dec;107(12):1895-1897. doi: 10.2105/AJPH.2017.304124. Epub 2017 Oct 19. No abstract available.


How 6 Organizations Developed Tools and Processes for Social Determinants of Health Screening in Primary Care: An Overview.

LaForge K, Gold R, Cottrell E, Bunce AE, Proser M, Hollombe C, Dambrun K, Cohen DJ, Clark KD.

J Ambul Care Manage. 2018 Jan/Mar;41(1):2-14. doi: 10.1097/JAC.0000000000000221.


The bouba-kiki effect and its relation to the Autism Quotient (AQ) in autistic adolescents.

Gold R, Segal O.

Res Dev Disabil. 2017 Dec;71:11-17. doi: 10.1016/j.ridd.2017.09.017. Epub 2017 Oct 5.


A new role for primary care teams in the United States after "Obamacare:" Track and improve health insurance coverage rates.

DeVoe J, Angier H, Hoopes M, Gold R.

Fam Med Community Health. 2016 Dec;4(4):63-67. doi: 10.15212/FMCH.2016.0117. Epub 2016 Dec 1.


Bortezomib in severe MuSK-antibody positive myasthenia gravis: first clinical experience.

Schneider-Gold C, Reinacher-Schick A, Ellrichmann G, Gold R.

Ther Adv Neurol Disord. 2017 Oct;10(10):339-341. doi: 10.1177/1756285617721093. Epub 2017 Jul 26. No abstract available.


Insight into Metabolic 1H-MRS Changes in Natalizumab Induced Progressive Multifocal Leukoencephalopathy Brain Lesions.

Schneider R, Bellenberg B, Hoepner R, Ellrichmann G, Gold R, Lukas C.

Front Neurol. 2017 Sep 5;8:454. doi: 10.3389/fneur.2017.00454. eCollection 2017.


Reversibility of the effects of natalizumab on peripheral immune cell dynamics in MS patients.

Plavina T, Muralidharan KK, Kuesters G, Mikol D, Evans K, Subramanyam M, Nestorov I, Chen Y, Dong Q, Ho PR, Amarante D, Adams A, De Sèze J, Fox R, Gold R, Jeffery D, Kappos L, Montalban X, Weinstock-Guttman B, Hartung HP, Cree BAC.

Neurology. 2017 Oct 10;89(15):1584-1593. doi: 10.1212/WNL.0000000000004485. Epub 2017 Sep 15.


Impact of combined sodium chloride and saturated long-chain fatty acid challenge on the differentiation of T helper cells in neuroinflammation.

Hammer A, Schliep A, Jörg S, Haghikia A, Gold R, Kleinewietfeld M, Müller DN, Linker RA.

J Neuroinflammation. 2017 Sep 12;14(1):184. doi: 10.1186/s12974-017-0954-y.


Efficacy of Chlorantraniliprole in Controlling Structural Infestations of the Eastern Subterranean Termite in the USA.

Jones SC, Vargo EL, Keefer TC, Labadie P, Scherer CW, Gallagher NT, Gold RE.

Insects. 2017 Aug 31;8(3). pii: E92. doi: 10.3390/insects8030092.


Unexpected additive effects of minocycline and hydroxychloroquine in models of multiple sclerosis: Prospective combination treatment for progressive disease?

Faissner S, Mahjoub Y, Mishra M, Haupeltshofer S, Hahn JN, Gold R, Koch M, Metz LM, Ben-Hur T, Yong VW.

Mult Scler. 2017 Aug 1:1352458517728811. doi: 10.1177/1352458517728811. [Epub ahead of print]


Severe refractory CIDP: a case series of 10 patients treated with bortezomib.

Pitarokoili K, Yoon MS, Kröger I, Reinacher-Schick A, Gold R, Schneider-Gold C.

J Neurol. 2017 Sep;264(9):2010-2020. doi: 10.1007/s00415-017-8599-4. Epub 2017 Aug 23.


Life before Roe.

Gold RB, Donovan MK.

Sci Am. 2017 Aug 15;317(3):58-59. doi: 10.1038/scientificamerican0917-58. No abstract available.


Efficacy and Tolerability of Delayed-release Dimethyl Fumarate in Black, Hispanic, and Asian Patients with Relapsing-Remitting Multiple Sclerosis: Post Hoc Integrated Analysis of DEFINE and CONFIRM.

Fox RJ, Gold R, Phillips JT, Okwuokenye M, Zhang A, Marantz JL.

Neurol Ther. 2017 Dec;6(2):175-187. doi: 10.1007/s40120-017-0077-5. Epub 2017 Aug 2.


Efficacy and Safety of Delayed-release Dimethyl Fumarate for Relapsing-remitting Multiple Sclerosis in Prior Interferon Users: An Integrated Analysis of DEFINE and CONFIRM.

Fernández Ó, Giovannoni G, Fox RJ, Gold R, Phillips JT, Potts J, Okwuokenye M, Marantz JL.

Clin Ther. 2017 Aug;39(8):1671-1679. doi: 10.1016/j.clinthera.2017.06.012. Epub 2017 Jul 25.


Designing Health Information Technology Tools to Prevent Gaps in Public Health Insurance.

Hall JD, Harding RL, DeVoe JE, Gold R, Angier H, Sumic A, Nelson CA, Likumahuwa-Ackman S, Cohen DJ.

J Innov Health Inform. 2017 Jun 23;24(2):900. doi: 10.14236/jhi.v24i2.900.


Dimethyl fumarate for patients with neuromyelitis optica spectrum disorder.

Pitarokoili K, Gold R.

Mult Scler. 2018 Mar;24(3):364-365. doi: 10.1177/1352458517717090. Epub 2017 Jul 27. No abstract available.


Developing Electronic Health Record (EHR) Strategies Related to Health Center Patients' Social Determinants of Health.

Gold R, Cottrell E, Bunce A, Middendorf M, Hollombe C, Cowburn S, Mahr P, Melgar G.

J Am Board Fam Med. 2017 Jul-Aug;30(4):428-447. doi: 10.3122/jabfm.2017.04.170046.


Unilateral right prosopometamorphopsia with positive "half-face-covering-test" after small occipitotemporal stroke.

Schroeder C, Schneider-Gold C, Behrendt V, Grüter T, Lukas C, Gold R, Krogias C.

J Neurol Sci. 2017 Aug 15;379:247-248. doi: 10.1016/j.jns.2017.06.025. Epub 2017 Jun 16. No abstract available.


Laquinimod treatment in the R6/2 mouse model.

Ellrichmann G, Blusch A, Fatoba O, Brunner J, Hayardeny L, Hayden M, Sehr D, Winklhofer KF, Saft C, Gold R.

Sci Rep. 2017 Jul 10;7(1):4947. doi: 10.1038/s41598-017-04990-1.


Aquaporin-4 antibodies in patients treated with natalizumab for suspected MS.

Gahlen A, Trampe AK, Haupeltshofer S, Ringelstein M, Aktas O, Berthele A, Wildemann B, Gold R, Jarius S, Kleiter I.

Neurol Neuroimmunol Neuroinflamm. 2017 Jun 16;4(4):e363. doi: 10.1212/NXI.0000000000000363. eCollection 2017 Jul.


Testosterone Differentially Affects T Cells and Neurons in Murine and Human Models of Neuroinflammation and Neurodegeneration.

Massa MG, David C, Jörg S, Berg J, Gisevius B, Hirschberg S, Linker RA, Gold R, Haghikia A.

Am J Pathol. 2017 Jul;187(7):1613-1622. doi: 10.1016/j.ajpath.2017.03.006.


Large coverage MR neurography in CIDP: diagnostic accuracy and electrophysiological correlation.

Kronlage M, Bäumer P, Pitarokoili K, Schwarz D, Schwehr V, Godel T, Heiland S, Gold R, Bendszus M, Yoon MS.

J Neurol. 2017 Jul;264(7):1434-1443. doi: 10.1007/s00415-017-8543-7. Epub 2017 Jun 15.


Anti-inflammatory and immunomodulatory potential of human immunoglobulin applied intrathecally in Lewis rat experimental autoimmune neuritis.

Pitarokoili K, Kohle F, Motte J, Fatoba O, Pedreiturria X, Gold R, Yoon MS.

J Neuroimmunol. 2017 Aug 15;309:58-67. doi: 10.1016/j.jneuroim.2017.05.008. Epub 2017 May 19.


Relevance of early cervical cord volume loss in the disease evolution of clinically isolated syndrome and early multiple sclerosis: a 2-year follow-up study.

Hagström IT, Schneider R, Bellenberg B, Salmen A, Weiler F, Köster O, Gold R, Lukas C.

J Neurol. 2017 Jul;264(7):1402-1412. doi: 10.1007/s00415-017-8537-5. Epub 2017 Jun 9.


Rho-associated protein kinase 2 (ROCK2): a new target of autoimmunity in paraneoplastic encephalitis.

Popkirov S, Ayzenberg I, Hahn S, Bauer J, Denno Y, Rieckhoff N, Radzimski C, Hans VH, Berg S, Roghmann F, Noldus J, Bien CG, Skodda S, Wellmer J, Stöcker W, Krogias C, Gold R, Schlegel U, Probst C, Komorowski L, Miske R, Kleiter I.

Acta Neuropathol Commun. 2017 May 29;5(1):40. doi: 10.1186/s40478-017-0447-3.


Management of patients with malignancies and secondary immunodeficiencies treated with immunoglobulins in clinical practice: Long-term data of the SIGNS study.

Reiser M, Borte M, Huscher D, Baumann U, Pittrow D, Sommer C, Stangel M, Fasshauer M, Gold R, Hensel M.

Eur J Haematol. 2017 Aug;99(2):169-177. doi: 10.1111/ejh.12900. Epub 2017 Jun 21.


Fingolimod attenuates experimental autoimmune neuritis and contributes to Schwann cell-mediated axonal protection.

Ambrosius B, Pitarokoili K, Schrewe L, Pedreiturria X, Motte J, Gold R.

J Neuroinflammation. 2017 Apr 26;14(1):92. doi: 10.1186/s12974-017-0864-z.


Metabolic profiles by 1H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML).

Schneider R, Bellenberg B, Hoepner R, Kolb EM, Ellrichmann G, Haghikia A, Gold R, Lukas C.

PLoS One. 2017 Apr 26;12(4):e0176415. doi: 10.1371/journal.pone.0176415. eCollection 2017.


Coronal Transcranial Sonography and M-Mode Tremor Frequency Determination in Parkinson's Disease and Essential Tremor.

Richter D, Woitalla D, Muhlack S, Gold R, Tönges L, Krogias C.

J Neuroimaging. 2017 Sep;27(5):524-530. doi: 10.1111/jon.12441. Epub 2017 Apr 20.


Supplemental Content

Support Center